Oversight of fast-track drug approval by FDA stuck in low gear, critics say.
Mike
M
Mitka
D017277:Drug Approval; D007024:Hypotension, Orthostatic / Q000188:drug therapy; D008879:Midodrine / Q000627:therapeutic use; D011358:Product Surveillance, Postmarketing; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D008879:Midodrine